BeOne Medicines (ONC) Other financing activities (2016 - 2026)
BeOne Medicines (ONC) posted quarterly Other financing activities of $23.9 million for Q1 2026, down 62.32% year-over-year from $63.4 million in Q1 2025, and down 87.84% quarter-over-quarter from $196.3 million in Q4 2025.
BeOne Medicines (ONC) Other financing activities (2016 - 2026) Analysis & Trends
BeOne Medicines (ONC) has reported Other financing activities for 11 consecutive years, with $23.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other financing activities fell 62.32% year-over-year to $23.9 million; the TTM figure through Mar 2026 stood at $156.8 million (up 204.06% YoY), while the FY2025 annual figure was $196.3 million, up 6442.7% from the prior year.
- Other financing activities declined to $23.9 million in Q1 2026 per ONC's latest filing, from $196.3 million in the prior quarter.
- Across five years, Other financing activities topped out at $196.3 million in Q4 2025 and bottomed at -$63.4 million in Q2 2025.
- Historically, Other financing activities has averaged $13.9 million across 5 years, with a median of $13.3 million in 2022.
- Annual changes were most pronounced in 2023 — Other financing activities plunged 545.42% — and 2025, when it soared 684.55%.
- BeOne Medicines' Other financing activities stood at -$35.7 million in 2022, then tumbled by 46.74% to -$52.4 million in 2023, then soared by 35.86% to -$33.6 million in 2024, then jumped by 684.55% to $196.3 million in 2025, then tumbled by 87.84% to $23.9 million in 2026.
- Business Quant data shows ONC's Other financing activities at $23.9 million in Q1 2026, $196.3 million in Q4 2025, and -$63.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.05 Mn |
| Jun 30, 2026 | 11.05 Mn |
| Mar 31, 2026 | 23.88 Mn |
| Mar 31, 2026 | 23.88 Mn |
| Dec 31, 2025 | 196.28 Mn |
| Dec 31, 2025 | 196.28 Mn |
| Jun 30, 2025 | -63.36 Mn |
| Jun 30, 2025 | -63.36 Mn |
| Mar 31, 2025 | 63.36 Mn |
| Mar 31, 2025 | 63.36 Mn |
| Dec 31, 2024 | -33.58 Mn |
| Dec 31, 2024 | -33.58 Mn |
| Sep 30, 2024 | 33.58 Mn |
| Sep 30, 2024 | 33.58 Mn |
| Jun 30, 2024 | -11.79 Mn |
| Jun 30, 2024 | -11.79 Mn |
| Mar 31, 2024 | 14.79 Mn |
| Mar 31, 2024 | 14.79 Mn |
| Dec 31, 2023 | -52.35 Mn |
| Dec 31, 2023 | -52.35 Mn |